Release Date: 12/12/17 11:41 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 412.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%